$2.35
-0.09-3.69%
Last update: Oct 16, 4:00 PM
$2.35
-0.09-3.69%
Editas Medicine Inc
EDITNASDAQ
Editas Medicine (EDIT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.25 | $-0.24 | $-0.38 |
| Actual | $-0.15 | $-0.26 | $-0.06 | $-0.28 |
| Surprise | +46.4% | -4.00% | +75.0% | +26.3% |
| Revenue | ||||
| Estimate | $2.6M | $6.5M | $7.9M | $3.6M |
| Actual | $11.9M | $2.8M | $24.7M | $7.5M |
| Surprise | +361.2% | -56.3% | +214.6% | +108.7% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.21 | $-0.20 | $-0.23 | $-0.24 |
| Revenue | ||||
| Consensus | $4.0M | $7.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $-0.15 | $-0.28 | 46.4 % |
| Q1 | May 5, 2026 | $-0.26 | $-0.25 | -4.00 % |
| Q4 | Mar 9, 2026 | $-0.06 | $-0.24 | 75.0 % |
| Q3 | Nov 10, 2025 | $-0.28 | $-0.38 | 26.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $11.90M | $2.58M | 361.2 % |
| Q1 | May 5, 2026 | $2.83M | $6.47M | -56.3 % |
| Q4 | Mar 9, 2026 | $24.74M | $7.86M | 214.6 % |
| Q3 | Nov 10, 2025 | $7.54M | $3.61M | 108.7 % |
